Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRIQK antisense RNA 1 (TRIQK-AS1) is a long non-coding RNA gene classified as a natural antisense transcript. Antisense RNAs can regulate gene expression at various stages—including transcription and post-transcriptional modification—often by forming double-stranded RNA with sense transcripts, modulating chromatin, or interfering with transcriptional machinery. While antisense RNAs overall are increasingly recognized for roles in epigenetic regulation and as potential disease modulators, there is currently no direct evidence in the scientific literature of a specific functional, pathological, or therapeutic role for TRIQK-AS1. The gene is cataloged in RNA gene databases, but further investigation is needed to determine its biological significance.
None described for drugs (not a direct drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TRIQK antisense RNA 1 (TRIQK-AS1).